Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses
Neurology News Network for the week ending May 1, 2021.
Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk
Neurology News Network for the week ending April 24, 2021.
Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab
Neurology News Network for the week ending April 17, 2021.
RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease
Neurology News Network for the week ending April 10, 2021.
HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS
Neurology News Network for the week ending April 3, 2021.
Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window
Neurology News Network for the week ending March 27, 2021.
Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD
Neurology News Network for the week ending March 20, 2021.
FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders
Neurology News Network for the week ending March 13, 2021.
Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term
Neurology News Network for the week ending March 6, 2021.
Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic
Neurology News Network for the week ending February 27, 2021.
JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles
Neurology News Network for the week ending February 20, 2021.
FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome
Neurology News Network for the week ending February 13, 2021.
Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy
Neurology News Network for the week ending February 6, 2021.
FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS
Neurology News Network for the week ending January 30, 2021.
FDA Approves TBI Blood Test, Causal Link Between Smoking and Subarachnoid Hemorrhage, Inconsistencies Across EEG Education
Neurology News Network for the week ending January 23, 2021.
Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures
Neurology News Network for the week ending January 16, 2021.
FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine
Neurology News Network for the week ending January 9, 2021.
Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept
Neurology News Network for the week ending January 2, 2021.
CBD Transdermal Gel Reduces Seizure Frequency, nVNS Improves Migraine, EDSS Accuracy Improvised
Neurology News Network for the week ending December 26, 2020.
FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS
Neurology News Network for the week ending December 19, 2020.
CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures
Neurology News Network for the week ending December 12, 2020.
Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation
Neurology News Network for the week ending December 5, 2020.
NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment
Neurology News Network for the week ending November 28, 2020.
Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease
Neurology News Network for the week ending November 21, 2020.
Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved
Neurology News Network for the week ending November 14, 2020.
PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published
Neurology News Network for the week ending November 7, 2020.
Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission
Neurology News Network for the week ending October 31, 2020.
JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit
Neurology News Network for the week ending October 24, 2020.
sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation
Neurology News Network for the week ending October 17, 2020.
Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan
Neurology News Network for the week ending October 10, 2020.